Furuya N, He K, Carbone DP. Patients' voice and passion lead to successful clinical trial, KISEKI study; Comments on "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progr Lung Cancer 2023;178:143-144.
PMID: 36858003